{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:35:03Z","timestamp":1781278503543,"version":"3.54.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008129","name":"Helsinn Group","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Anorexia is experienced by most people with lung cancer during the course of their disease and treatment. Anorexia reduces response to chemotherapy and the ability of patients to cope with, and complete their treatment leading to greater morbidity, poorer prognosis and outcomes. Despite the significant importance of cancer-related anorexia, current therapies are limited, have marginal benefits and unwarranted side effects. In this multi-site, randomised, double blind, placebo controlled, phase II trial, participants will be randomly assigned (1:1) to receive once-daily oral dosing of 100mg of anamorelin HCl or matched placebo for 12 weeks. Participants can then opt into an extension phase to receive blinded intervention for another 12 weeks (weeks 13\u201324) at the same dose and frequency. Adults (\u226518 years) with small cell lung cancer (SCLC); newly diagnosed with planned systemic therapy OR with first recurrence of disease following a documented disease-free interval \u22656 months, AND with anorexia (i.e., \u2264 37 points on the 12-item Functional Assessment of Anorexia Cachexia Treatment (FAACT A\/CS) scale) will be invited to participate. Primary outcomes are safety, desirability and feasibility outcomes related to participant recruitment, adherence to interventions, and completion of study tools to inform the design of a robust Phase III effectiveness trial. Secondary outcomes are the effects of study interventions on body weight and composition, functional status, nutritional intake, biochemistry, fatigue, harms, survival and quality of life. Primary and secondary efficacy analysis will be conducted at 12 weeks. Additional exploratory efficacy and safety analyses will also be conducted at 24 weeks to collect data over longer treatment duration. The feasibility of economic evaluations in Phase III trial will be assessed, including the indicative costs and benefits of anamorelin for SCLC to the healthcare system and society, the choice of methods for data collection and the future evaluation design.<jats:bold>Trial registration.<\/jats:bold>The trial has been registered with the Australian New Zealand Clinical Trials Registry [ACTRN12622000129785] and approved by the South Western Sydney Local Health District Human Research Ethics Committee [2021\/ETH11339].<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clin.larvol.com\/trial-detail\/ACTRN12622000129785\" xlink:type=\"simple\">https:\/\/clin.larvol.com\/trial-detail\/ACTRN12622000129785<\/jats:ext-link>.<\/jats:p>","DOI":"10.1371\/journal.pone.0285850","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T17:32:18Z","timestamp":1684344738000},"page":"e0285850","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Phase II, double blind, placebo controlled, multi-site study to evaluate the safety, feasibility and desirability of conducting a phase III study of anamorelin for anorexia in people with small cell lung cancer: A study protocol (LUANA trial)"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5034-9946","authenticated-orcid":true,"given":"Mariana S.","family":"Sousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1214-5149","authenticated-orcid":true,"given":"Peter","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6204-9158","authenticated-orcid":true,"given":"Miriam J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0189-0952","authenticated-orcid":true,"given":"Matthew","family":"Maddocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Bullock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6756-6119","authenticated-orcid":true,"given":"Meera","family":"Agar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3531-0389","authenticated-orcid":true,"given":"Slavica","family":"Kochovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Kinchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8725-9477","authenticated-orcid":true,"given":"Deidre","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Fazekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Razmovski-Naumovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica T.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malinda","family":"Itchins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1988-1250","authenticated-orcid":true,"given":"David C.","family":"Currow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"issue":"1","key":"pone.0285850.ref001","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12906-018-2304-8","article-title":"The management strategies of cancer-associated anorexia: a critical appraisal of systematic reviews","volume":"18","author":"F Zhang","year":"2018","journal-title":"BMC complementary and alternative medicine"},{"issue":"1","key":"pone.0285850.ref002","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.critrevonc.2012.02.011","article-title":"Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients","volume":"84","author":"M Trajkovic-Vidakovic","year":"2012","journal-title":"Critical reviews in oncology\/hematology"},{"key":"pone.0285850.ref003","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.critrevonc.2015.12.008","article-title":"Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: A systematic review","volume":"99","author":"R Tarricone","year":"2016","journal-title":"Critical reviews in oncology\/hematology"},{"issue":"4","key":"pone.0285850.ref004","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5001\/omj.2013.75","article-title":"Quality of life and nutritional status among cancer patients on chemotherapy","volume":"28","author":"N Vergara","year":"2013","journal-title":"Oman Med J"},{"issue":"4","key":"pone.0285850.ref005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","article-title":"The Global Burden of Cancer 2013","volume":"1","author":"C Fitzmaurice","year":"2015","journal-title":"JAMA oncology"},{"issue":"10","key":"pone.0285850.ref006","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","article-title":"Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?","volume":"90","author":"PJ Ross","year":"2004","journal-title":"British journal of cancer"},{"issue":"5","key":"pone.0285850.ref007","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0885-3924(03)00074-5","article-title":"Measuring the Symptom Experience of Seriously Ill Cancer and Noncancer Hospitalized Patients Near the End of Life with the Memorial Symptom Assessment Scale","volume":"25","author":"JE Tranmer","year":"2003","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"pone.0285850.ref008","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jcsm.12402","article-title":"Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review","volume":"10","author":"MS Anker","year":"2019","journal-title":"Journal of cachexia, sarcopenia and muscle"},{"issue":"5","key":"pone.0285850.ref009","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/fon.14.14","article-title":"Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome","volume":"10","author":"DC Currow","year":"2014","journal-title":"Future oncology (London, England)"},{"issue":"4","key":"pone.0285850.ref010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"JS Temel","year":"2016","journal-title":"The Lancet Oncology"},{"issue":"8","key":"pone.0285850.ref011","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/annonc\/mdx192","article-title":"ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia","volume":"28","author":"D Currow","year":"2017","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"5","key":"pone.0285850.ref012","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/1758834017698643","article-title":"Cancer-induced muscle wasting: latest findings in prevention and treatment","volume":"9","author":"Z Aversa","year":"2017","journal-title":"Therapeutic advances in medical oncology"},{"issue":"1","key":"pone.0285850.ref013","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcsm.12675","article-title":"The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers","volume":"12","author":"H Wakabayashi","year":"2021","journal-title":"Journal of cachexia, sarcopenia and muscle"},{"key":"pone.0285850.ref014","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2288-10-67","article-title":"What is a pilot or feasibility study? A review of current practice and editorial policy","volume":"10","author":"M Arain","year":"2010","journal-title":"BMC medical research methodology"},{"issue":"3","key":"pone.0285850.ref015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jclinepi.2011.07.011","article-title":"The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency","volume":"65","author":"J Sim","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"pone.0285850.ref016","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/pst.185","article-title":"Sample size of 12 per group rule of thumb for a pilot study","volume":"4","author":"SA Julious","year":"2005","journal-title":"Pharmaceutical Statistics"},{"issue":"6","key":"pone.0285850.ref017","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s11136-019-02135-7","article-title":"Comprehensive validation of the functional assessment of anorexia\/cachexia therapy (FAACT) anorexia\/cachexia subscale (A\/CS) in lung cancer patients with involuntary weight loss","volume":"28","author":"HL Gelhorn","year":"2019","journal-title":"Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation"},{"issue":"5","key":"pone.0285850.ref018","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"ME Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"3","key":"pone.0285850.ref019","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","article-title":"How to measure comorbidity: a critical review of available methods","volume":"56","author":"V De Groot","year":"2003","journal-title":"Journal of clinical epidemiology"},{"issue":"6","key":"pone.0285850.ref020","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"AS Levey","year":"1999","journal-title":"Annals of internal medicine"},{"key":"pone.0285850.ref021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-684X-4-7","article-title":"The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]","volume":"4","author":"AP Abernethy","year":"2005","journal-title":"BMC Palliat Care"},{"issue":"2","key":"pone.0285850.ref022","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1519\/00139143-200608000-00004","article-title":"Reference values for the timed up and go test: a descriptive meta-analysis","volume":"29","author":"RW Bohannon","year":"2006","journal-title":"Journal of geriatric physical therapy (2001)"},{"issue":"2","key":"pone.0285850.ref023","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00520-015-2826-2","article-title":"The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A\/CS and the VAS for appetite","volume":"24","author":"S Blauwhoff-Buskermolen","year":"2016","journal-title":"Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"2","key":"pone.0285850.ref024","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"JT Farrar","year":"2001","journal-title":"Pain"},{"issue":"10","key":"pone.0285850.ref025","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"M Herdman","year":"2011","journal-title":"Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation"},{"issue":"12","key":"pone.0285850.ref026","doi-asserted-by":"crossref","first-page":"e0189190","DOI":"10.1371\/journal.pone.0189190","article-title":"The EQ-5D-5L is a valid approach to measure health related quality of life in patients undergoing bariatric surgery","volume":"12","author":"JM Fermont","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"pone.0285850.ref027","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MEG.0000000000000762","article-title":"Higher quality of life after metal stent placement compared with plastic stent placement for malignant extrahepatic bile duct obstruction: a randomized controlled trial","volume":"29","author":"D Walter","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"pone.0285850.ref028","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.2147\/CMAR.S166713","article-title":"Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancer","volume":"10","author":"X Zhu","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"7","key":"pone.0285850.ref029","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s11136-012-0293-5","article-title":"An investigation of the construct validity of the ICECAP-A capability measure","volume":"22","author":"H Al-Janabi","year":"2013","journal-title":"Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation"},{"issue":"10","key":"pone.0285850.ref030","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s11136-015-0980-0","article-title":"A longitudinal assessment of the responsiveness of the ICECAP-A in a randomised controlled trial of a knee pain intervention","volume":"24","author":"T Keeley","year":"2015","journal-title":"Quality of Life Research"},{"issue":"12","key":"pone.0285850.ref031","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0895-4356(03)00220-8","article-title":"Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity","volume":"56","author":"GC Wendel-Vos","year":"2003","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"pone.0285850.ref032","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","article-title":"Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system","volume":"13","author":"SB Yellen","year":"1997","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"pone.0285850.ref033","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s11136-013-0616-1","article-title":"An investigation into the construct validity of the Carer Experience Scale (CES)","volume":"23","author":"I Goranitis","year":"2014","journal-title":"Quality of Life Research"},{"issue":"3","key":"pone.0285850.ref034","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/0272989X10381280","article-title":"Estimation of a preference-based carer experience scale","volume":"31","author":"H Al-Janabi","year":"2011","journal-title":"Medical decision making: an international journal of the Society for Medical Decision Making"},{"issue":"2","key":"pone.0285850.ref035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"EA Eisenhauer","year":"2009","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"1","key":"pone.0285850.ref036","doi-asserted-by":"crossref","DOI":"10.5301\/grhta.5000254","article-title":"The Feasibility Study: A Health Economics Perspective","volume":"4","author":"B. Gannon","year":"2017","journal-title":"Global & Regional Health Technology Assessment"},{"key":"pone.0285850.ref037","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the economic evaluation of health care programmes","author":"M. Drummond","year":"2005","edition":"3"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0285850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T05:59:54Z","timestamp":1702447194000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0285850"}},"subtitle":[],"editor":[{"given":"Junichi","family":"Matsubara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0285850","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]}}}